Industry Insights

31. Making Informed Decisions In Your Oncology Study: Understanding Biomarkers 6/18/2026

    Oncology biomarkers track tumor burden and reduce radiation from imaging. Composite algorithms improve response prediction. Fit-for-purpose strategies are needed to manage logistics and costs.

32. Navigating The New Landscape Of Oncology Clinical Trials: A Strategic Imperative For Operations Teams 6/18/2026

    The oncology landscape is growing but faces high screen-fail rates and trial complexity. To succeed, teams must move past traditional playbooks and adopt centralized pre-screening pipelines.

33. A Sponsor Playbook For Matching AI Use Cases To Readiness, Risk, And ROI 6/18/2026

    Clinical technology consultant Karen Maduschke explains why your next AI investment should solve a problem you can articulate, with data you can access, in a process you can change.

34. One Drug, Three Indications: How Small ClinOps Teams Manage Multi-Trial Execution 6/17/2026

    Having the same number of clinical programs as team members might sound crazy, but for Step Pharma, it has become one of their biggest strengths.

35. Rare Disease Nonprofits: De-Risk Development With Orphan Drug Designation And Early Talks With The FDA 6/17/2026

    For nonprofit organizations, Orphan Drug Designation is the start of a disciplined, forward-looking regulatory strategy, but it's not the only factor in success. H. Greg Thomas, Ph.D., shares his advice for de-risking orphan drug development.

36. Participants Don't Care How Your Vendor Stack Works 6/16/2026

    Participants experience one study, not the vendor stack behind it. Learn how sponsors and CROs can reduce burden with support built around real study needs.

37. Scaling Outsourced Clinical Trial Services 6/16/2026

    Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.

38. Financial Compliance In Clinical Trials Explained Clearly 6/16/2026

    An operational look at financial compliance in clinical trials, explaining how audit trails, traceability, and reporting function under real-world conditions, and why scale makes weak assumptions visible.

39. Participant Payments Without Site Burden 6/16/2026

    Participant payments can create extra work for clinical trial sites. Learn how clearer ownership, connected workflows, and direct support reduce site burden while preserving visibility.

40. How Intelligent IRT Is Redefining Clinical Supply Chains 6/16/2026

    Traditional clinical supply chains can't keep up. Learn how smart IRT platforms use real-time data to prevent shortages, cut waste, and keep trials running smoothly.